Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Comparison of Venlafaxine Augmentation With Quetiapine v.s. Placebo in Treatment Resistant Depression

NCT00253266 is registered in ClinicalTrials.gov with Max-Planck-Institute of Psychiatry as lead sponsor.

NCT NCT00253266
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00253266 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Comparison of Venlafaxine Augmentation With Quetiapine v.s. Placebo in Treatment Resistant Depression
Lead sponsor
Max-Planck-Institute of Psychiatry
Phase
Phase 4
Overall status
Completed
Start date
April 30, 2008
Completion date
August 31, 2014
Enrollment
126 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

depression